Skip to content
10-K/A

Annual Report

PROTO SCRIPT PHARMACEUTICAL CORP

0001640334-17-002207

← back to feed
Filed
Oct 19, 2017 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2016 · Sep 14, 2017 49.14M sh
Dividends Paid FY 2016 · Dec 31, 2016 $59.59K
Dividends Paid FY 2016 · Dec 31, 2015 $90.23K
Capex FY 2016 · Dec 31, 2016 $15.23K
Capex FY 2016 · Dec 31, 2015 $6.06K
Cash And Equivalents FY 2016 · Dec 31, 2016 $3.51K
Cash And Equivalents FY 2016 · Dec 31, 2015 $9.09K
Cash And Equivalents FY 2016 · Dec 31, 2014 $31.15K
Stockholders Equity FY 2016 · Dec 31, 2016 −$319.74K
Stockholders Equity FY 2016 · Dec 31, 2015 $62.24K
Stockholders Equity FY 2016 · Dec 31, 2014 $323.52K
Current Liabilities FY 2016 · Dec 31, 2016 $489.93K
Current Liabilities FY 2016 · Dec 31, 2015 $136.7K
Current Assets FY 2016 · Dec 31, 2016 $144.65K
Current Assets FY 2016 · Dec 31, 2015 $183.5K
Total Assets FY 2016 · Dec 31, 2016 $170.19K
Total Assets FY 2016 · Dec 31, 2015 $198.94K
Sga Expense FY 2016 · Dec 31, 2016 $862.55K
Sga Expense FY 2016 · Dec 31, 2015 $840.98K
Net Income FY 2016 · Dec 31, 2016 −$7.18M
Net Income FY 2016 · Dec 31, 2015 −$145.25K
Operating Income FY 2016 · Dec 31, 2016 −$298.08K
Operating Income FY 2016 · Dec 31, 2015 −$146.69K
Gross Profit FY 2016 · Dec 31, 2016 $564.47K
Gross Profit FY 2016 · Dec 31, 2015 $694.3K
Cost Of Revenue FY 2016 · Dec 31, 2016 $224.49K
Cost Of Revenue FY 2016 · Dec 31, 2015 $187.15K